Rodman & Renshaw Reiterates Buy Rating for Cellect … – The Cerbat Gem


The Cerbat Gem
Rodman & Renshaw Reiterates Buy Rating for Cellect ...
The Cerbat Gem
Rodman & Renshaw reissued their buy rating on shares of Cellect Biotechnology Ltd. American Depositary Shares (NASDAQ:APOP) in a research report ...
Stocks Given Top Analysts Ratings: Cellect Biotechnology Ltd. (:APOP) FuelCell Energy, Inc. (NASDAQ:FCEL)Rives Journal
Cellect Gets Green Light From FDA For ApoGraft IND Submission in ...GlobeNewswire (press release)

all 3 news articles »

Read the rest here:
Rodman & Renshaw Reiterates Buy Rating for Cellect ... - The Cerbat Gem

Related Posts

Comments are closed.